Advait Vasavada, CHEST 2022: In-hospital mortality of pulmonary embolism in young adults with cannabis use disorder

Cannabis use disorder is described as the inability to stop using marijuana, despite a negative impact on health. It was a pleasure to talk with Dr. Advait Vasavada (M. P. Shah Medical College, Jamnagar, India) around the aims, design, eligibility criteria and findings from his study investigating in-hospital mortality of pulmonary embolism in young adults with cannabis use disorder.

The abstract ‘CANNABIS USE DISORDER: FRIEND OR FOE IN PULMONARY EMBOLISM AND ASSOCIATED MORTALITY IN YOUNG ADULTS (AGED 18-44 YEARS)?’ (Poster 2051) was presented at CHEST 2022, 16-19 October, 2022.

Questions

1. What were the aims, design and eligibility criteria of your study? (0:25)
2. What were the findings of this study? (2:21)
3. What would you like to see as the next steps in this area? (4:01)

Disclosures: Advait Vasavada has nothing to disclose in relation to this video interview.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.

Filmed in coverage of the CHEST meeting 2022.